FGF23 and chronic kidney disease: Nakano et al. examined each independent association using a prospective cohort study of predialysis patients with CKD and identified serum concentrations of total 25(OH)D and intact FGF23, but not 1,25(OH)2D, as significant predictors of renal composite outcome of doubling serum creatinine and ESRD [17].